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Background 6"
 7"
Building research capacity in community pharmacy and advancing the research agenda is an 8"
aspiration of the British pharmacy profession. In 2013, the Royal Pharmaceutical Society (RPS) 9"
and Pharmacy Research UK (PRUK) introduced the ‘Research Ready’ scheme, developed to help 10"
community pharmacy teams become accredited to take part in research [1]. Translation of interest 11"
in research projects into active engagement of community pharmacists as research partners/co-12"
researchers remains a challenge. Previous studies in different countries have shown that the 13"
pressures of daily practice, and availability of time to participate, are key barriers to the active 14"
involvement of community pharmacists in pharmacy practice research [2-6]. 15"
  16"
Involving peers in specific research techniques with health professionals, such as interviewing, 17"
may enhance the validity of the results. This technique has been utilised previously during 18"
interviews conducted by doctors with peers [7]; respondents recognised the interviewer as a fellow 19"
clinician, resulting in broader and more personal accounts of their attitudes and behaviour in 20"
clinical practice. Another study, however, reflected on the pros and cons of peer interviewing in the 21"
health context; as an insider, the peer could gain potentially rich insights but their identity as a peer 22"
could affect the responses [8]. The authors concluded that the strategy used would depend on the 23"
individual study, and that involving both non-clinicians and clinicians in analysis may offset the 24"
drawbacks of either approach. 25"
 26"
A multi-phase pharmacy practice research study, exploring the emergency supply of prescription-27"
only medicines through community pharmacies, was undertaken between October 2012 and 28"
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November 2013. One phase of this study involved peer interviewing by community pharmacists to 29"
explore the dilemmas that they faced when making emergency supplies. 30"
 31"
Objective 32"
 33"
This study had two primary objectives: to describe and analyse emergency supply activity, and to 34"
explore how this service could form an integral component of health and social care pathways. The 35"
secondary objective was to enhance community pharmacists’ involvement in pharmacy practice 36"
research, and this is the focus of this short report. 37"
 38"
Ethical Approval 39"
This research project received a favourable opinion in October 2012 from The Black Country 40"
NRES (National Research Ethics Service) Committee in England. Fieldwork governance approval 41"
was granted by NHS Wirral, Western Cheshire, Liverpool, Sefton, Knowsley, Halton & St Helens 42"
(study ref 115122). 43"
 44"
Method 45"
Recruitment was undertaken by the Research Associate (RA), in conjunction with the former 46"
NorthWest Primary Care Research Network (PCRN). A number of approaches were employed to 47"
recruit a critical mass of study sites for this project (target 20). A research network gatekeeper sent 48"
an information pack (information sheet and consent form, with direct response to the RA) to 12 49"
pharmacies who had taken part in previous research capacity training, and 6 consented to 50"
participate but further sites were needed. The research network contact approached the head 51"
offices of several national multiples. The RA mailed every independent pharmacy on the published 52"
contractor list for each of the six localities granting research governance approval (n=249). They 53"
also approached pharmacies with existing University links. As the research network contact could 54"
not disclose her original invitation list, there is likely to have been duplication so we cannot 55"
calculate a definitive response rate; a rough estimate would suggest 10%. Participating 56"
pharmacies were selected to give diversity in ownership type, location and opening hours. 57"
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[Table 1 goes around here] 59"
 60"
Pharmacists had different roles in each phase of the study; an overview is given in Table 1. Whilst 61"
all pharmacists assisted the team in phases 1&3, a subgroup took on additional activities in phases 62"
2&4. The term ‘pharmacist researchers’ described the cohort of 27 volunteers. The secondary aim 63"
of the project focussed on broadening pharmacists’ knowledge of research methodology, including: 64"
processes for obtaining informed consent; maintaining confidentiality of data; recruitment of patient; 65"
and presenting findings in an accessible manner. In this short report, we will concentrate on the 66"
experience of the pharmacists who conducted telephone interviews with peers (referred to from 67"
now on as ‘interviewers’). 68"
 69"
For Phase 2 peer interviews, a one-day training workshop with a subgroup of pharmacists 70"
focussed on semi-structured telephone interviewing techniques. This workshop was run by the 71"
non-pharmacist RA and pharmacist academics from the project team. Training included: 72"
differences between research interviews and healthcare consultations; the process of obtaining 73"
consent; the use of recording equipment, and practical exercises to develop interviewing skills. 74"
Role play involved interviewers sitting back-to-back to perform a simulated telephone interview so 75"
that they could not read the body language of their ‘interviewee’. 76"
 77"
PRIs and participating pharmacies received token payments in recognition of their involvement in 78"
data collection. Second pharmacist fees were paid to ensure there was cover for interviewers to 79"
attend the telephone interview training workshop in Phase 2.  80"
"81"
Insights from the interviewer experience were obtained at the workshop using feedback forms and 82"
one-on-one reflexive sessions. The form included the opportunity to provide free text comments. 83"
The RA was in contact with the interviewers throughout the process in order to provide support and 84"
advice. Artefacts from this engagement included field notes made by the RA after conversations 85"
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and email messages. The RA, in discussion with other members of the research team, reflected 86"
upon the emerging themes from these artefacts, using a constant comparative qualitative approach. 87"
 88"
Results 89"
The total pharmacist researcher cohort was twenty-seven pharmacists working at twenty-two 90"
pharmacies in North West England with diverse settings and ownership type (Table 2). There was 91"
an almost even split of male (51.8%) and female (48.1%) pharmacists, representing all ages, and 92"
stages of career progression, including two pre-registration pharmacists.* 93"
 94"
[Insert Table 2 around here] 95"
 96"
There were five interviewers in Phase 2 (Table 2) - 3 female and 2 male - and they reflected the 97"
range of length of practice experience. Only one-quarter of the 27 sites (25.9%), however, were 98"
from large national companies, and so it was notable that 4 out of 5 of the interviewers were from 99"
large chains but the reasons for this were not explored.  100"
 101"
Positive effects 102"
The training workshop provided opportunities for interviewers to raise concerns, and these were 103"
revisited during the sessions to ensure they were addressed. They said that the peer learning 104"
approach of the workshops was helpful: 105"
“Being able to discuss apprehensions with colleagues.” (PI3 - form) 106"
 107"
Small group activities and practical exercises helped interviewers to build confidence:   108"
“It was a good format with great input from everybody. Having such a small group was 109"
most beneficial as it was much easier to communicate and chat informally also. 110"
Looking forward to completing the telephone surveys as the back to back training gave 111"
a good insight in what to expect and what not to do!”    (PI5 - form) 112"
"""""""""""""""""""""""""""""""""""""""" """"""""""""""""""""
*"Pre-registration pharmacists are in their first year of supervised practice after graduating. They assume full 
responsibilities as a pharmacist at the end of that year, subject to passing a professional registration examination."
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 113"
Most interviewers reported enjoying the opportunity to learn and apply new skills beyond their day-114"
to-day role. They were interested in the focus of the study – emergency supply of prescription-only 115"
medicines from community pharmacies – with many reporting dilemmas in their own practice: 116"
“It was extremely interesting being involved in a research project with other 117"
pharmacists and their views, as it opens up issues that you may not have thought 118"
about entirely, [such as] consequences of actions they have taken.”  (PI1 - 119"
conversation) 120"
 121"
The interviewers reflected afterwards that the interviews had enabled interviewees to be more 122"
open about issues encountered in practice. They also reported that their professional knowledge 123"
was useful in these interviews to probe effectively: 124"
“Generally feel that this made it easier to talk about issues and extract more detailed 125"
information from pharmacist interviewees – our ability to probe using our own 126"
experience; [during the interviews I conducted] I didn’t feel that judgements were being 127"
made pharmacist-pharmacist.” (PI5 - conversation) 128"
 129"
Challenges 130"
Balancing their involvement with existing work responsibilities was a challenge for the interviewers. 131"
One interviewer experienced difficulties in arranging and completing interviews as a result of 132"
pharmacy workload; three interviewees were subsequently reassigned to another interviewer. 133"
 134"
Despite a mutually convenient time being arranged between interviewers and interviewees, 135"
difficulties were experienced as many interviews were planned within the working day. 136"
Interviewees sometimes had to postpone their interviews as the pharmacy was busier than 137"
expected at the agreed time.  One interviewer reflected that some pharmacists she interviewed 138"
were short of time, which affected the interview quality as she felt she had to hurry: 139"
“I was very aware with both these [interviews] that the pharmacist was in a hurry to get 140"
back to the ‘day job’ so feel I was rushing a bit.” (PI3 - conversation) 141"
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 142"
Considerable time and effort from the RA was required to continue liaison, via personal visits and 143"
telephone contact.  144"
 145"
Conclusion 146"
A small cohort of community pharmacists successfully participated in peer interviewing for a study 147"
of community pharmacists’ dilemmas related to emergency supply of prescription-only medicines 148"
to patients. These pharmacists were necessarily self-selected - peer interviews required greater 149"
time commitment than other data collection phases. The interviewers reflected the broader 150"
demographics of the cohort, but over-represented large chain employers. There was widespread 151"
interest in the focus of the study, with many interviewers having encountered dilemmas in their own 152"
practice. This appeared to be a motivating factor for participation. 153"
 154"
The five interviewers had greater contact with the research team through attendance at the training 155"
workshop. This helped them to build deeper understanding of research processes such as 156"
obtaining informed consent and data confidentiality issues. 157"
 158"
While pharmacists reported the research activities stimulating and enjoyable, competing work 159"
pressures made the task challenging. Consideration therefore needs to be given to appropriate 160"
resourcing for including practising pharmacists in research. Seston et al. identified maintaining 161"
personal contact and communication with pharmacy staff involved in research studies as a key 162"
challenge [2]. This requires appropriate resourcing, including payment of fees for second 163"
pharmacists to cover the days that pharmacists spent at training workshops. 164"
 165"
Links have been made for these pharmacists to sign up to the RPS ‘Research Ready’ accreditation 166"
scheme which may promote their participation in future research studies [1]. 167"
 168"
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Table 1: Pharmacist involvement and training for each Project Phase 
 
Phase of Project CP research activities Research issues addressed Training and support given 
Phase 1: Clinical audit of 
emergency supplies in 
participating pharmacies over 
two four-week collection periods. 
(27 pharmacists) 
Data collection and reflection: 
pharmacists recorded data about 
the characteristics of emergency 
supplies of prescribed medicines, 
and also logged any related 
issues or dilemmas that arose for 
them at the time of supply. 
The importance of consistent and 
complete recording of robust 
quantitative data about practice 
for research. 
RA contact via telephone and 
pharmacy visits to provide 
encouragement, answer 
questions and maximise data 
quality.  
Phase 2: Semi-structured 
telephone interviews with 
pharmacists working at 
pharmacies across North West 
England. 
(5 pharmacists) 
Participation in a telephone 
interview. A subgroup of 
pharmacists were trained to 
conduct these peer-to-peer 
interviews to facilitate greater 
openness around difficult 
situations and dilemmas 
described. 
Obtaining informed consent for 
research. 
Developing skills to conduct 
semi-structured telephone 
interviewing techniques. 
 
A one-day training workshop on 
telephone interviewing skills.  
The RA debriefed interviewers 
via telephone after interviews 
and reviewed initial transcripts to 
explore any challenges and give 
advice. 
Phase 3: Follow-up interviews 
with service users who received 
emergency supplies/loans of 
prescription-only medicines. 
(27 pharmacists) 
Recruitment of patients who 
requested emergency supplies or 
loans for follow-up telephone 
interviews with the Research 
Associate. 
Patient recruitment processes 
(approaching patients, separating 
the recruitment process from 
patient care). 
The RA visited each pharmacist 
to offer instruction regarding the 
recruitment procedure, providing 
any further support needed by 
telephone. 
Phase 4: Qualitative interactive 
feedback sessions with medical 
practice teams. 
(7 pharmacists) 
A sub-group of pharmacists were 
trained to facilitate these 
sessions, which explored 
practice staff’s views and 
experiences regarding the 
emergency supply service and its 
impact on, and relevance to, their 
workflow and patient well-being. 
Developing skills in presenting 
interim study findings in an 
accessible manner, to obtain 
feedback from other 
professionals. 
Protecting patient anonymity 
when reporting results. 
A half-day training workshop to 
develop skills in presenting 
interim findings to medical 
practices and to eliciting their 
views. (11 pharmacists attended 
the training but only 7 were able 
to do the sessions.) 
!
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Table 2: Characteristics of participating pharmacists (n=27) and of interviewers (n=5) 
 
Characteristic Number of  
Pharmacists 
% of Total Pharmacists 
(n=27) (1 dpl) 
Number of  
Interviewers 
Gender  
Male 14 51.8 2 
Female 13 48.1 3 
    
Age Group  
18-25 5 18.5 1 
26-35 9 33.3 1 
36-45 1 3.7 0 
46-55 8 29.6 0 
56-65 1 3.7 1 
missing 3 11.1 2 
    
Community Pharmacy Practice Experience (years)  
Pre-registration 2 7.4 0 
1-2 4 14.8 1 
3-5 4 14.8 1 
6-10 7 25.9 1 
>10 10 37.0 2 
    
Type of Pharmacy Ownership  
Single independent pharmacy 5 18.5 0 
Small group of 2 to 5 pharmacies 3 11.1 0 
Local group of more than 5 pharmacies 12 44.4 1 
National group of over 100 pharmacies 7 25.9 4 
    
 
